Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ pathology are detected

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

EMBO Molecular Medicine

Topics

Biology

Neuroscience

Computer Science

Chemistry

Medicine

Show all topics

DOI

10.15252/emmm.202012921

License

CC-BY

Other Formats

PDF